Insulin glargine and lixisenatide Subcutaneous and Pinworm Medicine
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Pinworm Medicine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: pyrantel
Brand name: Antiminth, Ascarel, Pin-X, Pinworm Caplets, Pinworm Medicine, Pin-Away
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone and Glimepiride
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone and Glimepiride Tablets
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone and metformin
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone and Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide Subcutaneous-Pioglitazone and Metformin Tablets
- Pinworm Medicine-Insulin glargine, recombinant Subcutaneous
- Pinworm Medicine-Insulin glulisine
- Pinworm Medicine-Insulin Glulisine (Cartridges and Pens)
- Pinworm Medicine-Insulin Glulisine (Vials)
- Pinworm Medicine-Insulin glulisine Subcutaneous
- Pinworm Medicine-Insulin human inhaled Inhalation